Office on Women's Health - U.S. Department of Health and Human Services

12/10/2025

🔔 If you need a reminder to schedule that health screening here it is! Learn about what screenings are recommended for women across the lifespan with our “Screenings and Discussions for Every Stage of Life” fact sheet. http://ms.spr.ly/6188t9LYI

12/08/2025

📣 Continuing Medical Education (CME) Activity Alert!

🩺 Health care providers: The HHS Office on Women’s Health has released a CME activity, “Building Strength: A Guide for Prescribing Lifestyle Interventions for Sarcopenia," designed to help health care providers enhance their skills in screening to confidently prescribe lifestyle changes.

This course offers:
💻 CME/CE credit
📚 Practical, evidence-based strategies
💡 Strategies for identifying sarcopenia risk

Access the CME and earn credit today: http://ms.spr.ly/6180tjcEe

12/05/2025

📱 The Health Resources and Services Administration (HRSA)’s National Maternal Mental Health Hotline (1-833-TLC-MAMA) is a valuable resource for pregnant or postpartum individuals. It offers free, confidential support 24/7 in English & Spanish with interpreters supporting over 60 languages. Whether by text or call, professional counselors are here to listen and provide support. Learn more about the Hotline: http://ms.spr.ly/6184tjduk

12/04/2025

Living with postpartum depression (PPD) can feel like nothing will get better, but help and support are available. Explore options and find what works best for you. Learn more at http://ms.spr.ly/6188tjdVA.

12/03/2025

Changing hormone levels near menopause can affect your menstrual cycle and cause symptoms like hot flashes and problems sleeping. Though hot flashes are common for women in the year before their period stops and in the year after their period stops, hot flashes can continue for up to 14 years after menopause. Discover information on the symptoms of menopause and tips and resources on menopausal symptom relief. http://ms.spr.ly/6180tbstI

12/02/2025

: 📣 Continuing Medical Education (CME) Activity Alert!

Health care providers: The HHS Office on Women’s Health has released a CME activity, “From Risk Factors to Screening Strategies: The Latest in Breast Cancer.” This activity is designed to enhance your skills in screening and detecting .

This course offers:
💻 CME/CE credit
📚 Practical, evidence-based strategies
💡 Latest guidelines on breast cancer screening practices

Explore the course and earn credit today: http://ms.spr.ly/6184tbsWY.

12/01/2025

📣 New Publication Alert!

The HHS Office on Women’s Health is pleased to spotlight a recently published article in BMC Pregnancy and Childbirth. “Mortality-Weighted Severe Maternal Morbidity: A Novel Approach to Assessing Maternal Health Outcomes” examines maternal health outcomes and offers an improved metric that can help inform care practices, policies, and support systems for pregnant women. Access the full article here: http://ms.spr.ly/6184tbcIp

10/01/2025

09/29/2025

📣 New Continuing Medical Education (CME) Activity Alert!

Health care providers: Are you ready to enhance your knowledge on syphilis prevention strategies? The HHS Office on Women’s Health has released a new CME activity, “Improving Clinical Outcomes: Addressing Gaps in Syphilis and Congenital Syphilis.” This course is designed to strengthen skills in identifying, screening, and managing and .

This course offers:
💻 CME/CE credit
📚 Practical, evidence-based strategies
💡 Latest prevention guidelines and effective interventions to ensure healthier outcomes for mothers and infants

Explore the course and earn credit today: http://ms.spr.ly/6188sQyJa.

09/22/2025

📣 Are you a woman who has experienced and/or used hormone replacement therapy? The U.S. Food and Drug Administration is collecting comments!

FDA is interested in receiving public input on the risks and benefits related to menopause hormone therapy, including data that could support updates to the labeling of such products. Share your perspectives on risks and benefits concerning breast cancer, cardiovascular disease, genitourinary systems, bone health, and dementia.

This request is part of FDA’s effort to understand various perspectives on these safety considerations and the use of hormone therapy for menopause-related conditions in clinical practice. Comments must be received no later than 11:59 p.m. ET on September 24, 2025. Comment here: http://ms.spr.ly/6180sokMa

09/22/2025

📣 New Continuing Medical Education (CME) Activity Alert!

Health care providers: The HHS Office on Women’s Health has released a new CME activity, “Crucial Information for Your Practice on the Transition from Perimenopause to Postmenopause.” Learn to personalize care from perimenopause to postmenopause with evidence-based, patient-centered strategies in this CME/CE activity.

This course offers:
💻 CME/CE credit
📚 Practical, evidence-based strategies
💡 Latest patient-centered strategies

Explore the course and earn credit today: http://ms.spr.ly/6188sokxg.

09/19/2025

📣 The U.S. Food and Drug Administration is collecting comments! FDA has published a draft guide about including pregnant and breastfeeding women in clinical trials. This guide helps ensure medicines are safe and effective for these groups. You can share your comments until September 19, 2025. Learn more: http://ms.spr.ly/6180sWsR4